Cargando…
Risk stratification tools in prostate cancer, where do we stand?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844509/ https://www.ncbi.nlm.nih.gov/pubmed/33532290 http://dx.doi.org/10.21037/tau-20-1211 |
| _version_ | 1783644360431108096 |
|---|---|
| author | Clinckaert, Andries Devos, Gaëtan Roussel, Eduard Joniau, Steven |
| author_facet | Clinckaert, Andries Devos, Gaëtan Roussel, Eduard Joniau, Steven |
| author_sort | Clinckaert, Andries |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7844509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78445092021-02-01 Risk stratification tools in prostate cancer, where do we stand? Clinckaert, Andries Devos, Gaëtan Roussel, Eduard Joniau, Steven Transl Androl Urol Editorial Commentary AME Publishing Company 2021-01 /pmc/articles/PMC7844509/ /pubmed/33532290 http://dx.doi.org/10.21037/tau-20-1211 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Clinckaert, Andries Devos, Gaëtan Roussel, Eduard Joniau, Steven Risk stratification tools in prostate cancer, where do we stand? |
| title | Risk stratification tools in prostate cancer, where do we stand? |
| title_full | Risk stratification tools in prostate cancer, where do we stand? |
| title_fullStr | Risk stratification tools in prostate cancer, where do we stand? |
| title_full_unstemmed | Risk stratification tools in prostate cancer, where do we stand? |
| title_short | Risk stratification tools in prostate cancer, where do we stand? |
| title_sort | risk stratification tools in prostate cancer, where do we stand? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844509/ https://www.ncbi.nlm.nih.gov/pubmed/33532290 http://dx.doi.org/10.21037/tau-20-1211 |
| work_keys_str_mv | AT clinckaertandries riskstratificationtoolsinprostatecancerwheredowestand AT devosgaetan riskstratificationtoolsinprostatecancerwheredowestand AT rousseleduard riskstratificationtoolsinprostatecancerwheredowestand AT joniausteven riskstratificationtoolsinprostatecancerwheredowestand |